[Glutamate antagonists in treatment and rehabilitation of patients with postherpetic neuralgia].
The article is devoted to modern views of the pathogenesis of postherpetic neuralgia, the risks of its occurrence in patients with herpetic ganglionitis and treatment in the acute period to prevent the development of chronic pain, as well as in the treatment of already developed postherpetic neuralgia with the use of glutamate receptors antagonists.
T N
TN
Slobodin
D000284:Administration, Oral; D000547:Amantadine / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000627:therapeutic use*; D016697:Herpes Zoster Oticus / Q000378:metabolism / Q000534:rehabilitation*; D006801:Humans; D007275:Injections, Intravenous; D051474:Neuralgia, Postherpetic / Q000378:metabolism / Q000534:rehabilitation*
D018691:Excitatory Amino Acid Antagonists; D000547:Amantadine